Authors

• Steve McCune (ORCID: https://orcid.org/0000-0002-2207-9341)
• Eric Gauthier
• Timothy Pluard (ORCID: https://orcid.org/0000-0002-3640-3077)
• Monica Z. Montelongo (ORCID: https://orcid.org/0009-0002-3679-7202)
• Joanne L. Blum (ORCID: https://orcid.org/0000-0002-7951-6645)
• Daniel C. Anderson (ORCID: https://orcid.org/0000-0002-9826-9811)
• Zhe Zhang (ORCID: https://orcid.org/0009-0009-7615-6865)
• Joseph C. Cappelleri (ORCID: https://orcid.org/0000-0001-9586-0748)
• Gabrielle Betty Rocque (ORCID: https://orcid.org/0000-0003-4188-9785)
• Debu Tripathy (ORCID: https://orcid.org/0000-0002-5711-2404)
• Abigail Johnston

Institutions

• WellStar Health System (US)
• The University of Texas MD Anderson Cancer Center (US)
• Pfizer (United States) (US)
• Texas Oncology (US)
• University of Alabama at Birmingham (US)
• Optical Physics Company (United States) (US)
• Electronics for Imaging (United States) (US)
• La Jolla Alcohol Research (US)
• Metro-Minnesota Community Oncology Research Consortium (US)
• Saint Luke's Hospital (US)
• HealthPartners (US)
• Montgomery County Community College (US)
• National Patient Safety Foundation (US)

Publication Details

Journal

Future Oncology

Published

2025-10-27

DOI

https://doi.org/10.1080/14796694.2025.2570468

Primary Topic

Advanced Breast Cancer Therapies

Type

article

Field-Weighted Citation Impact

0.00